A Phase I, Open-label, Randomized, 4-period Crossover Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of K-285 Compared With a Single Oral Dose of Indomethacin Capsule in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 24 Jan 2019
At a glance
- Drugs Dilazep (Primary) ; Indometacin
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Kowa Research Institute
- 16 Jan 2019 Status changed from active, no longer recruiting to completed.
- 17 Dec 2018 Planned End Date changed from 1 Nov 2018 to 12 Dec 2018.
- 17 Dec 2018 Status changed from not yet recruiting to active, no longer recruiting.